It is a review article describing the application of neuroproteomic strategies for in-depth molecular characterization of OB in Alzheimer's and Parkinson's disease, establishing a relationship between the progression of the disease and deregulated proteins. It focuses the cholinergic system as responsible for the molecular mechanisms that cause olfactory dysfunction in these pathologies, and links to the BDNF pathway that has to do with the survival of the cholinergic cells, describing routes of BDNF action that are modified in the different stages of the pathologies.
Although they refer to papers already published, for a better understanding, a more explicit list or summary of proteostatic imbalance present in the OB from AD and PD subjects would be appreciated, to If it is a route, it would be the same, with modifications in both stages of the disease. They would have to put themselves in the same disposition, to see the modifications between one and another stage of the disease.
